US$ 25.24
semaglutide with metformin vs Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial niceguidelines #metformin #semaglutide #tirzepatide |
Description
But it appears to decrease your hunger level and make you feel full soon after eating or for a longer time after taking your meals
While many weight loss medications act directly on the brain to suppress appetite, GLP-1 receptor agonists work through multiple pathways, including the gut and pancreas

Clinical trials have shown that many patients using GLP-1 medications can lose a substantial portion of their body weight, with some studies reporting reductions of up to 20%

This effect helps patients consume fewer calories and avoid overeating, which can further aid in weight management and overall health

Barrett, E., Ross, R

GLP-1 receptor agonists produce modest but meaningful improvements in cholesterol and triglyceride levels, though lipid reduction is not their primary indication
